{"product_id":"spasfon-suppositories-10-suppositories","title":"Spasfon Suppositories 10 Suppositories","description":"\u003cp data-mce-fragment=\"1\"\u003eSpasfon\u003c\/p\u003e\n\u003cp\u003eSpasfon suppositories are a type of medicine used to treat pain caused by spasms (sudden, involuntary muscle contractions) in areas such as your intestines, bile ducts, bladder, and uterus. This medicine is only meant for adults.\u003c\/p\u003e\n\u003cp\u003eEach Spasfon suppository contains a substance called hydrated phloroglucinol, which helps to relax these spasms and relieve pain.\u003c\/p\u003e\n\u003cp\u003eIf you're experiencing stomach aches, the usual dose is one suppository, three times a day, with at least two hours between each one. But remember, don't use more than three in a day. This medicine isn't for kids.\u003c\/p\u003e\n\u003cp\u003eKeep in mind that Spasfon suppositories treat symptoms, so if your pain continues, you should get in touch with your doctor.\u003c\/p\u003e\n\u003cp\u003eYou shouldn't use Spasfon suppositories if you're allergic to any ingredients in them. Signs of an allergic reaction could include itching, skin rashes, swelling of your face or neck, sudden discomfort, or a red, scaly rash with fever. If you notice any of these signs, stop using the suppositories and contact a doctor right away.\u003c\/p\u003e\n\u003cp\u003eWhile this medicine can be used during pregnancy if needed, it's not recommended for breastfeeding women. Always seek advice from a healthcare professional before taking any new medicine. And if you forget a dose, don't double up on the next one.\u003c\/p\u003e\n\u003cp\u003eThe Spasfon suppositories come in a box of 10.\u003c\/p\u003e\n\u003cp\u003eIf you're pregnant and having contractions, your gynecologist might prescribe Spasfon suppositories and advise you to rest. A special cushion shaped like a banana or half-moon, like the Sissel cushion, can help you rest more comfortably.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eare a type of medicine used to treat pain caused by spasms (sudden, involuntary muscle contractions) in areas such as your intestines, bile ducts, bladder, and uterus. This medicine is only meant for adults.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eEach Spasfon suppository contains a substance called hydrated phloroglucinol, which helps to relax these spasms and relieve pain.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eIf you're experiencing stomach aches, the usual dose is one suppository, three times a day, with at least two hours between each one. But remember, don't use more than three in a day. This medicine isn't for kids.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eKeep in mind that Spasfon suppositories treat symptoms, so if your pain continues, you should get in touch with your doctor.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eYou shouldn't use Spasfon suppositories if you're allergic to any ingredients in them. Signs of an allergic reaction could include itching, skin rashes, swelling of your face or neck, sudden discomfort, or a red, scaly rash with fever. If you notice any of these signs, stop using the suppositories and contact a doctor right away.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eWhile this medicine can be used during pregnancy if needed, it's not recommended for breastfeeding women. Always seek advice from a healthcare professional before taking any new medicine. And if you forget a dose, don't double up on the next one.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eThe Spasfon suppositories come in a box of 10.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003eIf you're pregnant and having contractions, your gynecologist might prescribe Spasfon suppositories and advise you to rest. A special cushion shaped like a banana or half-moon, like the Sissel cushion, can help you rest more comfortably.\u003c\/p\u003e\n\u003cp data-mce-fragment=\"1\"\u003e\u003cspan style=\"color: #ff2a00;\"\u003e\u003cstrong\u003ePlease read full disclosure.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003ePRODUCT CHARACTERISTICS SUMMARY\u003c\/p\u003e\n\u003cp\u003eANSM - Updated on: 20\/09\/2022\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eNAME OF THE MEDICINE\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eSPASFON, suppository\u003c\/p\u003e\n\u003col start=\"2\"\u003e\n\u003cli\u003eQUALITATIVE AND QUANTITATIVE COMPOSITION\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eHydrated Phloroglucinol ................................................................................................. 150.0 mg\u003c\/p\u003e\n\u003cp\u003eQuantity corresponding to anhydrous Phloroglucinol ..................................................... 116.7 mg\u003c\/p\u003e\n\u003cp\u003eTrimethylphloroglucinol ................................................................................................ 150.0 mg\u003c\/p\u003e\n\u003cp\u003ePer suppository.\u003c\/p\u003e\n\u003cp\u003eFor the complete list of excipients, see section 6.1.\u003c\/p\u003e\n\u003col start=\"3\"\u003e\n\u003cli\u003ePHARMACEUTICAL FORM\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eSuppository.\u003c\/p\u003e\n\u003col start=\"4\"\u003e\n\u003cli\u003eCLINICAL DATA\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e4.1. Therapeutic indications\u003c\/p\u003e\n\u003cp\u003e· Symptomatic treatment of pain related to functional disorders of the digestive tract and bile ducts.\u003c\/p\u003e\n\u003cp\u003e· Treatment of acute spasmodic and painful manifestations of the urinary tract: kidney colic.\u003c\/p\u003e\n\u003cp\u003e· Symptomatic treatment of painful spasmodic manifestations in gynecology.\u003c\/p\u003e\n\u003cp\u003e· Adjuvant treatment of contractions during pregnancy in association with rest.\u003c\/p\u003e\n\u003cp\u003e4.2. Dosage and method of administration\u003c\/p\u003e\n\u003cp\u003eSpasfon is a symptomatic treatment. If symptoms persist, the patient's condition should be reassessed.\u003c\/p\u003e\n\u003cp\u003eReserved for adults.\u003c\/p\u003e\n\u003cp\u003eDosage\u003c\/p\u003e\n\u003cp\u003eThe usual dosage is 1 suppository per intake, three times a day, maintaining a minimum interval of 2 hours between each intake without exceeding 3 suppositories per 24 hours.\u003c\/p\u003e\n\u003cp\u003ePediatric Population\u003c\/p\u003e\n\u003cp\u003eThis dosage is not suitable for children.\u003c\/p\u003e\n\u003cp\u003eMethod of Administration\u003c\/p\u003e\n\u003cp\u003eRectal route.\u003c\/p\u003e\n\u003cp\u003e4.3. Contraindications\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients mentioned in section 6.1.\u003c\/p\u003e\n\u003cp\u003e4.4. Special warnings and precautions for use\u003c\/p\u003e\n\u003cp\u003eThe association of phloroglucinol with major analgesics such as morphine or its derivatives should be avoided due to their spasmogenic effect.\u003c\/p\u003e\n\u003cp\u003e4.5. Interactions with other medicines and other forms of interactions\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003cp\u003e4.6. Fertility, pregnancy and breastfeeding\u003c\/p\u003e\n\u003cp\u003ePregnancy\u003c\/p\u003e\n\u003cp\u003eStudies carried out in animals have not shown any teratogenic effect of phloroglucinol. In the absence of a teratogenic effect in animals, a malformative effect in the human species is not expected. Indeed, to date, the substances responsible for malformations in the human species have proven to be teratogenic in animals during well-conducted studies on two species.\u003c\/p\u003e\n\u003cp\u003eIn clinical practice, the relatively widespread use of phloroglucinol has apparently not revealed any malformative risk to date. However, epidemiological studies are necessary to verify the absence of risk.\u003c\/p\u003e\n\u003cp\u003eConsequently, the use of phloroglucinol should only be considered during pregnancy if advised by your doctor to be necessary.\u003c\/p\u003e\n\u003cp\u003eBreastfeeding\u003c\/p\u003e\n\u003cp\u003eIn the absence of data, it is advised to avoid the use of this medicine during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e4.7. Effects on ability to drive and use machines\u003c\/p\u003e\n\u003cp\u003eSPASFON has no or negligible effect on the ability to drive and use machines.\u003c\/p\u003e\n\u003cp\u003e4.8. Adverse effects\u003c\/p\u003e\n\u003cp\u003eThe following adverse effects are classified according to the organ system class and their frequency: indeterminate frequency (cannot be estimated based on the available data).\u003c\/p\u003e\n\u003cdiv class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\"\u003e\n\u003cdiv class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\"\u003e\n\u003cdiv class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\"\u003e\n\u003cdiv class=\"flex flex-grow flex-col gap-3\"\u003e\n\u003cdiv class=\"min-h-[20px] flex flex-col items-start gap-4 whitespace-pre-wrap break-words\"\u003e\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert light\"\u003e\n\u003cdiv class=\"flex-1 overflow-hidden\"\u003e\n\u003cdiv class=\"react-scroll-to-bottom--css-fooai-79elbk h-full dark:bg-gray-800\"\u003e\n\u003cdiv class=\"react-scroll-to-bottom--css-fooai-1n7m0yu\"\u003e\n\u003cdiv class=\"flex flex-col text-sm dark:bg-gray-800\"\u003e\n\u003cdiv class=\"group w-full text-gray-800 dark:text-gray-100 border-b border-black\/10 dark:border-gray-900\/50 bg-gray-50 dark:bg-[#444654]\"\u003e\n\u003cdiv class=\"flex p-4 gap-4 text-base md:gap-6 md:max-w-2xl lg:max-w-[38rem] xl:max-w-3xl md:py-6 lg:px-0 m-auto\"\u003e\n\u003cdiv class=\"relative flex w-[calc(100%-50px)] flex-col gap-1 md:gap-3 lg:w-[calc(100%-115px)]\"\u003e\n\u003cdiv class=\"flex flex-grow flex-col gap-3\"\u003e\n\u003cdiv class=\"min-h-[20px] flex flex-col items-start gap-4 whitespace-pre-wrap break-words\"\u003e\n\u003cdiv class=\"markdown prose w-full break-words dark:prose-invert light\"\u003e\n\u003cp\u003eOrgan System Class\u003c\/p\u003e\n\u003cp\u003eAdverse Effect-Preferred Term\u003c\/p\u003e\n\u003cp\u003eFrequency\u003c\/p\u003e\n\u003cp\u003eSkin and Subcutaneous Tissue Disorders\u003c\/p\u003e\n\u003cp\u003eRash, rarely urticaria, pruritus, exceptionally Quincke's edema, acute generalized exanthematous pustulosis\u003c\/p\u003e\n\u003cp\u003eIndeterminate Frequency\u003c\/p\u003e\n\u003cp\u003eImmune System Disorders\u003c\/p\u003e\n\u003cp\u003eAnaphylactic shock (low blood pressure)\u003c\/p\u003e\n\u003cp\u003eIndeterminate Frequency\u003c\/p\u003e\n\u003cp\u003eDeclaration of Suspected Adverse Effects\u003c\/p\u003e\n\u003cp\u003eThe declaration of suspected adverse effects after the authorization of the medicine is important. It allows for continuous monitoring of the benefit\/risk ratio of the medicine. Healthcare professionals report any suspected adverse effect via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: \u003ca href=\"http:\/\/www.signalement-sante.gouv.fr\/\" target=\"_new\"\u003ewww.signalement-sante.gouv.fr\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e4.9. Overdose\u003c\/p\u003e\n\u003cp\u003eCases of overdose have been reported without specific symptomatology.\u003c\/p\u003e\n\u003col start=\"5\"\u003e\n\u003cli\u003ePHARMACOLOGICAL PROPERTIES\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e5.1. Pharmacodynamic Properties\u003c\/p\u003e\n\u003cp\u003ePharmacotherapeutic class: MUSCULOTROPIC ANTISPASMODIC, ATC code: A03AX12 (A: Digestive system and metabolism) (G: Genitourinary system)\u003c\/p\u003e\n\u003cp\u003eMechanism of Action\u003c\/p\u003e\n\u003cp\u003ePhloroglucinol and trimethylphloroglucinol have a spasmolytic activity on smooth muscles and a visceral anti-nociceptive effect, particularly in the aftermath of episodes of acute pain.\u003c\/p\u003e\n\u003cp\u003e5.2. Pharmacokinetic Properties\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003cp\u003e5.3. Preclinical Safety Data\u003c\/p\u003e\n\u003cp\u003eNon-clinical data from conventional studies of repeated dose toxicity, genotoxicity and reproductive functions have not revealed any particular risk for humans.\u003c\/p\u003e\n\u003col start=\"6\"\u003e\n\u003cli\u003ePHARMACEUTICAL DATA\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e6.1. List of Excipients\u003c\/p\u003e\n\u003cp\u003eSemi-synthetic solid glycerides.\u003c\/p\u003e\n\u003cp\u003e6.2. Incompatibilities\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003cp\u003e6.3. Shelf Life\u003c\/p\u003e\n\u003cp\u003e3 years.\u003c\/p\u003e\n\u003cp\u003e6.4. Special Precautions for Storage\u003c\/p\u003e\n\u003cp\u003eKeep away from heat.\u003c\/p\u003e\n\u003cp\u003e6.5. Nature and Contents of Outer Packaging\u003c\/p\u003e\n\u003cp\u003e10 or 100 suppositories in blister packs (Opaque PVC).\u003c\/p\u003e\n\u003cp\u003e6.6. Special Precautions for Disposal and Handling\u003c\/p\u003e\n\u003cp\u003eNo special requirements for disposal.\u003c\/p\u003e\n\u003col start=\"7\"\u003e\n\u003cli\u003eMARKETING AUTHORIZATION HOLDER\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eACINO FRANCE SAS\u003c\/p\u003e\n\u003cp\u003e76-78, AVENUE DU MIDI\u003c\/p\u003e\n\u003cp\u003e63800 COURNON-D’AUVERGNE\u003c\/p\u003e\n\u003col start=\"8\"\u003e\n\u003cli\u003eMARKETING AUTHORIZATION NUMBER(S)\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e· 34009 309 861 4 1: 10 suppositories in blister packs (Opaque PVC).\u003c\/p\u003e\n\u003cp\u003e· 34009 352 431 8 8: 100 suppositories in blister packs (Opaque PVC).\u003c\/p\u003e\n\u003col start=\"9\"\u003e\n\u003cli\u003eDATE OF FIRST AUTHORIZATION\/RENEWAL OF THE AUTHORIZATION\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e[To be completed later by the holder]\u003c\/p\u003e\n\u003col start=\"10\"\u003e\n\u003cli\u003eDATE OF UPDATE OF THE TEXT\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e[To be completed later by the holder]\u003c\/p\u003e\n\u003col start=\"11\"\u003e\n\u003cli\u003eDOSIMETRY\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003col start=\"12\"\u003e\n\u003cli\u003eINSTRUCTIONS FOR THE PREPARATION OF RADIOPHARMACEUTICALS\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e\n\u003cp\u003ePRESCRIPTION AND SUPPLY CONDITIONS\u003c\/p\u003e\n\u003cp\u003eMedicine not subject to medical prescription.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Pharmarcie.com","offers":[{"title":"Default Title","offer_id":42617070780588,"sku":"P3400930986141","price":15.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0604\/4047\/7868\/files\/Spasfonsupose.jpg?v=1687445515","url":"https:\/\/pharmarcie.com\/products\/spasfon-suppositories-10-suppositories","provider":"Pharmarcie.com","version":"1.0","type":"link"}